Imagen de Portada

Letter: Gas‐Sensing Capsules Advance Colonic Physiology Research Toward Clinical Translation

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Anastasios Koulaouzidis, Wojciech Marlicz
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Alimentary Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Letter: Balancing Cost and Consequence of Colon Capsule Endoscopy in Colorectal Cancer Pathways—Finding the Sweet Spot
por: Ian Io Lei, et al.
Publicado: (2025)

Letter on ‘Telemetric Assessment and Comparison of Regional Colonic Metabolic Activity in Ambulant Healthy Individuals Using pH and Gas‐Sensing Wireless Motility Capsules’: Authors' Reply
por: Phoebe A. Thwaites, et al.
Publicado: (2025)

Telemetric Assessment and Comparison of Regional Colonic Metabolic Activity in Ambulant Healthy Individuals Using pH and Gas‐Sensing Wireless Motility Capsules
por: Phoebe A. Thwaites, et al.
Publicado: (2025)

Letter: H. pylori Infection May Constitute a Risk Factor for Reflux Disease and Colonic Neoplasia
por: Jannis Kountouras, et al.
Publicado: (2025)

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease
por: Jiacheng Li
Publicado: (2026)

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply
por: José Luis Rueda García, et al.
Publicado: (2026)

Letter: Geographic Transportability of Shingles Risk With Advanced IBD Therapies
por: Guofu Mao, et al.
Publicado: (2026)

Letter: Toward Intra‐Class Switching With JAK Inhibitors?
por: Mathieu Uzzan, et al.
Publicado: (2025)

Research Communication: Reflux Disease May Constitute a Risk Factor for Colonic Neoplasia
por: Amnon Sonnenberg, et al.
Publicado: (2025)

Letter: Toward Intra‐Class Switching With JAK Inhibitors? Authors' Reply
por: Shintaro Akiyama, et al.
Publicado: (2025)

Letter: The Unresolved Issue of NSBB Confounding in Statin Research for Cirrhosis
por: Deliang Huang, et al.
Publicado: (2026)

Letter: Late Diagnosis of Chronic Hepatitis B—Quantifying the Missed Opportunities and Clinical Consequences
por: Bi‐Yu Gao, et al.
Publicado: (2025)

Letter: Advancing Serologic Classification in Indeterminate Chronic Hepatitis B Through Dynamic and Integrated Frameworks
por: Chun‐Chieh Chen, et al.
Publicado: (2025)

Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
por: Lukas Burghart, et al.
Publicado: (2026)

Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing?
por: Qiang Hu, et al.
Publicado: (2024)

Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
por: Shoko Miyahara, et al.
Publicado: (2025)

Letter: Re‐Examining Seton Efficacy in Perianal Crohn's Disease—Considerations for Outcome Measurement and Clinical Interpretation
por: Dingsheng Liu, et al.
Publicado: (2025)

Letter: Advancing Serologic Classification in Indeterminate Chronic Hepatitis B Through Dynamic and Integrated Frameworks—Authors' Reply
por: Rui Huang, et al.
Publicado: (2025)

Letter: Beyond Survival Benefit in CHANCE2311—Important Considerations in the Interpretation of TACE Combined With Immunotherapy in Advanced HCC
por: Yinghan Chen, et al.
Publicado: (2026)

Letter on ‘Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis’
por: Yi Pei, et al.
Publicado: (2025)

Letter: From Descriptive Epidemiology to Clinical Imperative—Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease
por: DuJiang Yang, et al.
Publicado: (2025)

Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors. Authors' Reply
por: Merle Claßen, et al.
Publicado: (2024)

Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing? Authors' Reply
por: Yewan Park, et al.
Publicado: (2024)

Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor: Authors' Reply
por: Kee Huat Chuah, et al.
Publicado: (2025)

Letter: Methodological Flaws and Clinical Gaps—A Critique of TAF / TDF 5‐Year Data in East Asian CHB
por: Zhiyao Shi, et al.
Publicado: (2025)

Letter: Safety and Tolerability of Injectable Extended Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease
por: Xing Bai, et al.
Publicado: (2025)

Letter: Re‐Examining Seton Efficacy in Perianal Crohn's Disease—Critical Considerations for Outcome Measurement and Clinical Interpretation. Authors' Reply
por: Jeffrey D. McCurdy, et al.
Publicado: (2025)

Letter: Safety and Tolerability of Injectable Extended‐Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease—Authors' Reply
por: Luis Antonio Díaz, et al.
Publicado: (2025)

Letter: Irritable bowel syndrome and antibiotics
por: George F. Longstreth
Publicado: (2024)

Letter: Intestinal Ultrasound‐Prioritising Progress
por: Kacie H. Denton, et al.
Publicado: (2026)

Letter: Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT ‐ UC Consortium
por: Brian C. Weiner
Publicado: (2025)

Letter: Tenofovir Alafenamide—The “Star of Potential” for Long‐Term Chronic Hepatitis B Treatment. A Deep‐Dive Analysis of Phase 3 Clinical Trials
por: YaoYao Dai, et al.
Publicado: (2025)

Letter: Resmetirom for treatment of MASH with children and adolescents
por: Yong‐Hai Zhou, et al.
Publicado: (2024)

Letter: Steroid Tapering—Is Shorter Duration Better?
por: Juntao Lu, et al.
Publicado: (2026)

Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
por: José Luis Rueda García, et al.
Publicado: (2026)

Letter: Post‐HCV Cure, Precision Assessment of Liver Stiffness and Diabetes Risk in Maternal Populations—A Critical Research Need
por: Zihe Guan, et al.
Publicado: (2025)

Letter: Temporal Trends in the Rate of Colectomy in Ulcerative Colitis
por: Richard Pollok
Publicado: (2025)

Letter: Helicobacter pylori and Eosinophilic Oesophagitis—Lost in Definition?
por: Fernanda Cristofori, et al.
Publicado: (2025)

Letter: Predictors of Corticosteroid Response in Alcohol‐Related Hepatitis
por: Ewan Forrest, et al.
Publicado: (2025)

Letter: Irritable bowel syndrome and antibiotics—Authors' reply
por: Kyle Staller, et al.
Publicado: (2024)